The Answer is B: Chronic Active Hepatitis
Chronic active hepatitis is NOT a characteristic feature of systemic sclerosis. This is a straightforward question testing knowledge of classic SSc manifestations versus unrelated conditions.
Why Chronic Active Hepatitis is the Exception
Chronic active hepatitis is not part of the systemic sclerosis disease spectrum. While SSc is a multisystem autoimmune disease affecting skin, vasculature, and multiple internal organs, hepatic involvement in the form of chronic active hepatitis is not a recognized manifestation 1.
Why the Other Options ARE Characteristic of SSc
Pulmonary Fibrosis (Option A) - CORRECT Feature
- Interstitial lung disease occurs in 40-75% of SSc patients and is progressive in 15-18% 1
- This is one of the major causes of morbidity and mortality in SSc
- Current guidelines recommend mycophenolate mofetil as first-line therapy, with nintedanib for progressive fibrotic disease 2, 1
Positive Antinuclear Antibodies in 90% (Option C) - CORRECT Feature
- ANAs are detected in 90-95% of systemic sclerosis patients 3
- SSc-specific antibodies include anti-topoisomerase I (anti-Scl-70), anticentromere, and anti-RNA polymerase III
- These antibodies help predict organ involvement and prognosis 3, 4
Lower Esophageal Dysmotility (Option D) - CORRECT Feature
- Gastrointestinal involvement affects nearly 90% of SSc patients, with the esophagus being the most commonly involved organ 1
- Gastroesophageal reflux disease and esophageal dysmotility are prominent features 5, 6
- Proton pump inhibitors are the mainstay of treatment 5
Raynaud's Syndrome (Option E) - CORRECT Feature
- Nearly all patients with SSc have Raynaud's phenomenon 1
- This is often one of the earliest manifestations and is included in diagnostic criteria 4, 6
- Treatment includes calcium channel blockers (especially nifedipine) as first-line, followed by phosphodiesterase-5 inhibitors or IV iloprost 1
Clinical Pitfall to Avoid
Do not confuse the presence of positive autoantibodies in SSc with other autoimmune liver diseases like autoimmune hepatitis or primary biliary cholangitis. While these conditions may share autoimmune features, chronic active hepatitis is not an organ manifestation of systemic sclerosis itself 1.